Drug Diaries

Why is the UK a global leader in scientific discovery? Prof Chris Molloy joins us to discuss the future of UK life sciences.The UK has long been at the forefront of global invention, anchored by a unique network of world-leading universities and brilliant research talent. This conversation examines the foundations of that success and why the current environment remains so fertile for groundbreaking scientific discovery.We also look at the entrepreneurs converting these academic breakthroughs into tangible solutions. It is about more than just research; it is about building sustainable biotech startups capable of delivering real-world medical innovation that has the potential to save millions of lives.Subscribe for weekly insights on the business of healthcare, and let me know in the comments if you believe the UK can maintain its competitive edge in research.Chapters 00:00 The threat and opportunity in UK science 00:27 Why innovation needs to stay in the UK 01:24 What kind of life sciences nation does the UK want to be? 02:22 Professor Chris Molloy’s career journey 03:17 From pharma to biotech and informatics 05:04 Building the Medicines Discovery Catapult 09:04 The role of the Bioindustry Association 11:25 Carrying science into leadership 13:29 Misunderstandings about UK life sciences 17:09 UK’s long-term inventiveness and ambition 19:38 The UK’s biotech superpower 22:56 UK as a global biotech hub 24:05 Why successful companies often leave the UK 28:12 Bridging science and business 32:48 What government can do for biotech 34:37 Impact of biotech on patients and society 37:46 Speeding up medicine development 40:08 Why biotech should be regionalized 45:16 Birmingham’s unique biotech opportunities 47:58 What a thriving biotech ecosystem looks like 52:24 Connecting regional clusters for growth 54:14 Vision for UK biotech in 2036 57:14 Challenges and concerns for UK biotech 01:00:13 The importance of confidence and purpose 01:04:02 The collective responsibility for biotech success 01:04:44 Final thoughts and future outlookGet vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

Liquid biopsies could change how we detect cancer, but what happens when you are caught in the waiting period for a diagnosis?Jeff Bousfield shares his personal account of finding a concerning symptom and the subsequent wait for a cystoscopy. This period of medical uncertainty highlights the intense emotional toll patients experience while navigating the system.Beyond the personal story, we look at the role of the NHS in managing these diagnostic pathways. We examine how new testing methods like liquid biopsies aim to reduce the anxiety caused by long waits and provide faster answers for those facing a potential cancer diagnosis.Subscribe for weekly healthcare infrastructure breakdowns, and let me know in the comments how you think diagnostic wait times could be improved.Chapters 00:00 Introduction to Nonicus and cancer diagnostics 03:28 The patient experience: Waiting and anxiety 08:03 Leadership lessons from scaling startups to pharma 16:01 Reflections on career and future aspirations 18:40 Psychological impact of invasive procedures 22:23 The role of cystoscopy and how Galeas complements it 24:25 The patient pathway: From GP to diagnosis 26:09 Speeding up diagnosis: From sample to report 28:20 Decentralized testing and NHS integration 29:31 Explaining Galeas to a 12-year-old 33:11 Detecting recurrence and early relapse 34:58 Clinical trials and data endpoints 36:54 Test accuracy and predictive values 39:23 False positives and improving confidence 40:21 Analogy of airport security screening 41:07 Operational challenges in scaling up 44:23 Experience from COVID testing scale-up 47:37 The Birmingham ecosystem and Life Sciences Week 48:21 Core message for the upcoming event 49:21 Closing remarks and future outlookGet vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

As we get older, our immune memory wanes, leaving us vulnerable to infections. Learn why this happens and what to watch for.Just as we experience cognitive changes with age, our aging immune system becomes less efficient at recognising pathogens. This natural decline means the body is slower to respond to threats, which significantly increases the risk of serious illness. We look at the biological reality of this process and why it makes older adults more susceptible to common infections. Exclusive Access: Life Sciences Week 2026 (#LSW26)!We are thrilled to announce that Drug Diaries is partnering with Life Sciences Week 2026 (21–25 September 2026), the UK’s premier gathering for biotech, pharma, med-tech, AI, and healthcare policy leaders! Join 3,000+ industry pioneers, policymakers, and investors as we dive deep into the future of healthcare innovation. Seats are filling fast—secure your spot today with our exclusive community discount! 🎟️ Register Now: https://lifesciencesweek.co.uk/attend/⚡ Exclusive Discount Code: DRUGDIARIES10 (Use at checkout for an exclusive discount!)Don't wait—claim your ticket now and be part of the national conversation shaping life sciences!Subscribe for weekly health insights, and let me know in the comments if you have questions about immune health.0:00 The Hidden Toll of Modern Survival 0:45 Meet the Professor Behind the Lab Bench 7:20 From Medical Student to Immunology Expert 11:52 Why Survival Is No Longer Sufficient 18:17 Demystifying Secondary Immune Deficiency 31:24 The Long Road to Patient Recovery 38:30 The Unsung Hero of Modern Healthcare 52:45 The Power of Public-Private Partnerships 1:14:04 A Vision for the Future of Healthcare

In this conversation, Kaushik Trivedi interviews Professor Andrew Beggs, a pioneering figure in cancer genetics and surgery. They discuss the traditional approaches to cancer treatment and how Andrew's dual role as a surgeon and scientist allows him to bridge the gap between immediate patient care and long-term research. Andrew shares his personal journey, including moments of self-doubt, the emotional challenges of balancing surgery and research, and the sacrifices made in pursuit of excellence. The conversation also touches on the evolution of cancer understanding, the importance of collaboration in research, and the future of cancer treatment through genomics and immunotherapy. In this conversation, Andrew Beggs discusses the transformative potential of liquid biopsies, advancements in precision therapy, and the future of organoid technology in cancer treatment. He highlights the challenges in organoid culture and the revolutionary impact of long-read genomic sequencing. The discussion also covers the role of AI in cancer diagnostics, the emerging innovation hub in the West Midlands, and the barriers to biotech advancement in the UK. Finally, they touch on the significance of Life Sciences Week as a platform for fostering collaboration and innovation in the healthcare sector.Exclusive Access: Life Sciences Week 2026 (#LSW26)!We are thrilled to announce that Drug Diaries is partnering with Life Sciences Week 2026 (21–25 September 2026), the UK’s premier gathering for biotech, pharma, med-tech, AI, and healthcare policy leaders! Join 3,000+ industry pioneers, policymakers, and investors as we dive deep into the future of healthcare innovation. Seats are filling fast—secure your spot today with our exclusive community discount! 🎟️ Register Now: https://lifesciencesweek.co.uk/attend/ ⚡ Exclusive Discount Code: DRUGDIARIES10 (Use at checkout for an exclusive discount!)Don't wait—claim your ticket now and be part of the national conversation shaping life sciences!Chapters 00:00 Introduction to Andrew Beggs and his dual role in surgery and science 02:44 Andrew's motivation for combining surgery with genomics research 04:23 Early influences and the evolution of Andrew’s career 06:31 Overcoming self-doubt and career setbacks 09:48 Spark for cancer genetics and core beliefs changed 12:24 Handling emotional challenges of patient outcomes 14:29 Balancing clinical intensity with scientific research 16:01 Personal sacrifices and leadership in high-stakes environments 17:17 Lessons on leading multidisciplinary teams 21:19 Explaining cancer heterogeneity to a child 22:38 Progress in cancer genomics and immunotherapy 24:06 Liquid biopsy and its revolutionary potential 27:25 Organoids and personalized drug testing 34:48 Advances in long-read sequencing technology 37:50 AI in cancer diagnostics and research 40:48 Predicting immune responses with AI and genomics 42:22 West Midlands as a biotech innovation hub 47:43 Future of cancer treatment and diagnostic breakthroughs in 10 years Get vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

How one pharmaceutical development project generated 50 billion dollars despite management trying to kill it. See the high-stakes reality.In this episode, Dr. David Brown shares his 52-year journey in drug discovery, the transformative potential of AI in medicine, and the urgent need for the pharmaceutical industry to embrace paradigm shifts to reduce human suffering.You will hear the inside perspective of a clinical development committee meeting where the project was faced with a three-month deadline to prove efficacy or face total termination. This is for anyone interested in the friction between medical research and corporate budget constraints.Learn how drug discovery survives when budgets are cut to zero and leadership demands immediate results. We examine the tension of professional life when your career hinges on proving the viability of a vital medical treatment. Understand the pressure of navigating complex clinical trials while your own company actively attempts to shut you down.Subscribe for weekly career breakdowns and tell me, have you ever had to fight for a project you believed in against all odds?Chapters 0:00 The $50 Billion Discovery That Almost Never Was 5:05 From Punch Cards to AI-Driven Medicine 9:10 Why AI Must Be the Foundation, Not a Bolt-On 14:07 The Stagnation of Big Pharma's Financial Engine 18:06 The 90-Day Thread: A Project Hanging by a Wire 25:03 The Lightbulb Moment: Connecting the Dots 35:55 Navigating Power Plays in Legacy Organizations 42:21 Mapping Mountains and Valleys with AIGet vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

In this episode, Kaushik Trivedi interviews Professor Neil Hanley about the transformative healthcare innovations happening in the West Midlands, UK. They explore regional collaboration, cutting-edge research, and the future of data-driven medicine.As a thank you to the Drug Diaries Podcast community, I am pleased to share an exclusive 10% discount for Life Sciences Week 2026. Use code: DRUGDIARIES10https://lifesciencesweek.co.uk/conference-launch-tickets/ Chapters 00:00 Introduction to the West Midlands healthcare revolution 01:19 Neil Hanley's role in shaping UK health innovation 03:10 Neil Hanley's early career and scientific inspiration 11:13 The concept of the golden parallelogram in UK science 14:41 The strategic importance of Birmingham's diverse healthcare ecosystem 20:58 The Birmingham Health Innovation Campus and its facilities 25:31 Co-locating startups, scientists, and healthcare providers 32:44 Data-driven healthcare and AI in preventative medicine 38:44 Future directions in aging, longevity, and gene therapy 48:53 Neil Hanley's legacy and vision for BirminghamGet vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

This discussion breaks down the current state of artificial intelligence integration within the pharmaceutical sector. We examine why scaling AI solutions is a major hurdle for many organisations and how to overcome the gap between technical capability and actual deployment. This is essential viewing for anyone trying to navigate the complexities of adopting advanced technologies in a highly regulated environment.If you are a vendor selling to pharma, the advice provided here is critical. We discuss why generic pitches fail and why presenting concrete AI business cases is the only way to secure buy-in from stakeholders. Instead of focusing on hype, learn how to demonstrate measurable ROI and operational efficiency to decision-makers who need to see real-world results before committing to new partnerships.Subscribe for weekly B2B strategy breakdowns, and comment below on which industry sector you want us to analyse next.Chapters 00:00 Introduction to AI's role in healthcare decision-making 02:28 Flora Eduard's background and industry transformation 06:40 The surprising lack of data use in pharma decision-making 08:11 Leadership principles Flora refuses to compromise 12:45 Cultural insights from working across countries 16:08 Biggest setbacks and lessons learned 22:39 Digital transformation vs. digitization 28:41 Current state of AI experimentation in pharma 31:52 Understanding agentic AI and its differences from traditional AI 34:45 The future of AI and how soon it will arrive 40:49 AI's potential to improve patient outcomes 45:33 Skills needed for future leaders in the AI era 01:10:10 The future of pharma in 2035 01:11:48 Rapid fire insights and predictionsGet vidIQ to grow your channel faster! 🚀https://vidiq.com/DrugDiaries Learn how to approach AI in pharma by focusing on proven business cases rather than theoretical potential. Discover what works today.

Stop sending mass emails that land you on a blacklist. Learn why mass email practices hurt healthcare communication and how Maya offers a better way.Sending unsolicited bulk emails to entire departments is a fast way to get your domain blocked. This video explains the mechanics behind vendor blacklisting and why standard mass outreach strategies often fail in clinical environments. If you are struggling with low engagement or deliverability issues, understanding these risks is the first step toward fixing your outreach.We discuss the concept of Maya as a potential path forward. The core takeaway is that even the most advanced technical solutions fail if they do not fit the specific communication landscape of healthcare. We analyze why context and recipient relevance matter more than volume when you are trying to reach busy medical professionals.Subscribe for weekly email deliverability breakdowns, and comment below if you have ever faced a domain blacklist issue.keywordshealthcare innovation, pharma digital transformation, content experience, AI in pharma, networking, pilot projects, healthcare technologykey topicsThe importance of authentic human connection in healthcare Challenges and opportunities in pharma digital transformation The future of AI and agentic technology in healthcare Effective networking and relationship building in pharma Scaling pilots and proof of concepts for long-term successguest name: Gaurav SanganeeChapters00:00 The Crisis in Healthcare Communication02:59 Breaking Away from Convention05:25 The Role of Closing Delta and Relato08:12 Navigating the Challenges of Pilots and Proof of Concepts10:46 The Importance of Incremental Change13:09 The Static Content Crisis in Pharma15:41 The Future of Healthcare Communication31:06 The Evolution of Content Delivery35:44 Transforming Scientific Content Presentation41:02 Embracing New Technologies in Pharma47:30 The Future of Healthcare Tech52:46 Rapid Fire Insights and ReflectionsResourcesFounder - The MacDonald Story - https://www.imdb.com/title/tt0107048/Maverick - https://www.imdb.com/title/tt1631867/Relayto Content Experience Platform - https://relayto.com/Closing Delta - https://www.linkedin.com/company/closing-delta/about/Guest linksLinkedIn: https://www.linkedin.com/in/gaurav-sanganee/Get vidIQ to grow your channel faster! 🚀https://vidiq.com/DrugDiaries

In this conversation, Kaushik Trivedi speaks with Jennifer Kane Burk Mosa, who has navigated a diverse career as a diplomat, healthcare executive, entrepreneur, and comedian. They explore the themes of curiosity, impact, and the importance of understanding human behavior in various sectors, particularly healthcare. Jennifer emphasizes the need for collaboration and listening to patients to create meaningful solutions in healthcare systems. The discussion also touches on the challenges of transitioning from public to private healthcare and the complexities of global health initiatives. In this conversation, Jennifer Cain Birkose discusses the importance of understanding patient interactions with technology and the role of ethnography in pharmaceutical development. She highlights the mission of Viva Valley in supporting older adults to live independently and delves into the implications of the MFN policy on drug pricing and access. Additionally, she explains the critical role of market access professionals in navigating the complexities of the pharmaceutical industry and provides insights into a typical day in their lives. In this conversation, Jennifer Cain Birkose and Kaushik Trivedi explore the critical role of patient involvement in healthcare, the definition of independence for older adults, and the importance of quality of life over mere longevity. They discuss the lessons learned from older generations, the surprising journey into comedy, and how improv can serve as a valuable tool for leadership. The conversation also touches on the connection between laughter and trust, the embrace of nonlinear career paths, and the transformative power of the phrase 'Yes, And' in both personal and professional contexts.Chapters 00:00 The Courage to Become Many Things 02:16 Curiosity and Impact: A Life of Many Roles 06:50 The Thread of Impact in Healthcare and Beyond 11:27 Diplomacy and Human Behavior: Understanding Incentives 13:53 Transitioning from Public to Private Healthcare 20:50 Global Health Initiatives: Collaboration is Key 24:24 Listening to Patients: The Missing Voice in Healthcare 27:36 Understanding Patient Interactions with Technology 30:30 The Role of Ethnography in Pharma Development 31:45 Viva Valley: Supporting Independent Living for Older Adults 33:14 Exploring the MFN Policy and Its Implications 45:04 The Role of Market Access Professionals in Pharma 55:35 A Day in the Life of a Market Access Professional 57:53 The Importance of Patient Involvement 01:01:14 Defining Independence for Older Adults 01:04:30 Quality of Life vs. Length of Life 01:08:31 Lessons from Older Generations 01:10:23 The Surprising Journey into Comedy 01:13:10 Improv as a Leadership Tool 01:17:27 The Connection Between Laughter and Trust 01:22:04 Embracing Nonlinear Career Paths 01:23:58 The Power of 'Yes, And'Guest LinkedIn: https://protect.checkpoint.com/v2/r01/___https://www.linkedin.com/in/jennifer-cain-birkmose-ab05a6?utm_source=share_via&utm_content=profile&utm_medium=member_ios___.YzJ1OmFlc2FyYTE6YzpvOjQ2ZWVmZGEzMDY0YTU1OTlkYTFkZjVjM2YyMzQ5NWZjOjc6YzBmNDpiYjVhZjU0NGIxZTRkYThmMTkxYzU2NWYyNmZiMGM4YjQzMDAzNTU1YjNkZTFiOTFhZjY1MTJkNDQ5ZjIwYWFkOmg6VDpGAesara: www.aesara.com MMV: https://www.mmv.org/Vivavalet: www.vivavalet.comTed talks https://www.ted.com/search?q=jennifer%20cain%20birkmose INC article reference: https://www.inc.com/suzanne-lucas/look-for-these-5-traits-to-find-your-high-potential-employees/91198182

Explore the fascinating science of skin biology with Benjamin Fuchs, a skincare expert with over 45 years of experience. Discover how internal health, nutrition, and cellular processes influence skin aging, acne, and overall skin health. In this episode, Benjamin Fuchs discusses the science behind skin health, debunks common skincare myths, and shares practical advice on how to support skin from the inside out. Discover how internal nutrition, proper skincare ingredients, and understanding skin signals can transform your approach to skin health.keywords skin biology, skincare science, collagen, hydration, aging, cellular health, skin care tips, Benjamin Fuchs skin health, skincare myths, internal nutrition, acne treatment, skincare ingredients, dermatology, skin aging, topical nutrients, skincare tips, health and wellnesstakeaways Skin is a living, breathing biochemical organ, not just a surface. Supporting internal health and blood circulation is key to skin health. Most skincare products disrupt the skin's electrical and biological processes. Exfoliation and supporting natural cell turnover strengthen skin. Structured water and supporting collagen production are vital for hydration.guest nameBenjamin FuchsChapters00:00 Understanding Skin: The Overlooked Organ02:56 The Science of Skin: Beyond Surface Level05:58 The Bioelectrical Nature of Skin08:48 Skin Structure: Layers and Functions12:04 The Journey of Skin Cells14:53 Hydration vs. Moisturization: The Real Difference18:02 The Role of Blood in Skin Health20:57 Topical Solutions: What Really Works?24:11 Exfoliation: The Key to Healthy Skin34:59 The Science of Exfoliation38:20 Understanding Structured Water43:58 The Role of Collagen in Aging48:44 Factors Contributing to Collagen Decline52:59 Why Does Skin Age? 55:25 The Impact of Skin Tone on Aging56:42 Acne: Understanding True vs Faux01:08:05 Skincare Strategies for Teenagers01:13:34 The Dangers of Benzoyl Peroxide01:16:05 The Superiority of Salicylic Acid01:18:38 The Importance of Active Ingredients01:20:50 Nutritional Foundations for Skin Health01:24:41 Understanding Skincare Labels01:25:35 Key Principles for Skin Health01:26:14 Rapid Fire Myths and Facts01:31:17 Debunking Skincare Trends01:35:59 The Truth About Moisturizers01:37:27 Final Thoughts on Skin HealthResources Benjamin Fuchs' Website Vitamin A Supplements Zinc for Skin Health Selenium Supplements Salicylic Acid Topical Treatments Chemical Sunscreens and Alternatives Topical Nutrients for Skin